Inventor · disambiguated record
Sean Ekins
Also filed as: EKINS SEAN
8 granted patents·13 pending applications·12 citations·filing 2001–2023
78Inventor score
Files withCOLLABORATIONS PHARMACEUTICALS INC6EKINS SEAN3PFIZER2UNIV RUTGERS2LA BIOMEDICAL RES INSTITUTE AT HARBOR UCLA MEDICAL CENTER1
Top patents by PatentIndex Score
21 records- 0185US11696914B1Use of pyronaridine, tilorone, and quinacrine against Marburg virus and other virus infectionsCOLLABORATIONS PHARMACEUTICALS INC·Filed 2020·Granted Jul 11, 2023·4 cites·5 claims
- 0270US11186549B2Therapeutic indazolesUNIV RUTGERS·Filed 2018·Granted Nov 30, 2021·1 cites·12 claims
- 0366US6564152B2Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonistsPFIZER·Filed 2001·Granted May 13, 2003·7 cites·15 claims
- 0466US2024009183A1Use of pyronaridine, tilorone, and quinacrine against marburg virus and other virus infectionsCOLLABORATIONS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0563US12060330B2Therapeutic indazolesUNIV RUTGERS·Filed 2021·Granted Aug 13, 2024·0 cites·14 claims
- 0656US2007219768A1System and method for prediction of drug metabolism, toxicity, mode of action, and side effects of novel small molecule compoundsEKINS SEAN·Filed 2006·Application pending·0 cites
- 0756US2012029896A1System and method for prediction of drug metabolism, toxicity, mode of action, and side effects of novel small molecule compoundsEKINS SEAN·Filed 2011·Application pending·0 cites
- 0854US8211882B2Glutamate receptor modulators and therapeutic agentsWOOD RICHARD DELAREY·Filed 2009·Granted Jul 3, 2012·0 cites·8 claims
- 0953US2010250218A1System and method for prediction of drug metabolism, toxicity, mode of action, and side effects of novel small molecule compoundsEKINS SEAN·Filed 2010·Application pending·0 cites
- 1053US2025332170A1Vandetanib reduces inflammatory cytokines and ameliorates covid-19COLLABORATIONS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1149US2025179033A1New antiviral triazole derivatives, their synthesis and their use for treatment of mammalian viral infectionsCOLLABORATIONS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1248US2021015906A1Enzyme replacement therapy for mucopolysaccharidosis iiidLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2020·Application pending·0 cites
- 1347US2024296914A1Uv-vis spectra predictionCOLLABORATIONS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1444US2003069699A1Device for drug-drug interaction testing sample preparationFiled 2002·Application pending·0 cites
- 1544US2023330045A1The antiviral drug tilorone is a potent and selective inhibitor of acetylcholinesteraseCOLLABORATIONS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1643US11382875B2Methods and compositions for modulating β-amyloid/α7-nAChR interactionsLUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER·Filed 2018·Granted Jul 12, 2022·0 cites·7 claims
- 1743US10695322B2Inhibitors of bacterial growthUNIV JOHNS HOPKINS·Filed 2017·Granted Jun 30, 2020·0 cites·15 claims
- 1842US2018221459A1Enzyme replacement therapy for mucopolysaccharidosis iiidLA BIOMEDICAL RES INSTITUTE AT HARBOR UCLA MEDICAL CENTER·Filed 2018·Application pending·0 cites
- 1935US6489094B2Method and device for drug-drug interaction testing sample preparationPFIZER·Filed 2001·Granted Dec 3, 2002·0 cites·3 claims
- 2034US2002016681A1Single point interaction screen to predict IC50Filed 2001·Application pending·0 cites
- 2132US2002013372A1Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitorsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean Ekins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →